Synergistic Multi-Signal Fluorescent Probe System for Enhanced Tumor Diagnosis and Treatment

A novel system integrating a multi-signal fluorescent probe with distinct technologies such as AI, IoT, blockchain, and new materials to revolutionize tumor diagnosis and treatment planning.

The original patent disclosed a multi-signal fluorescent probe for early tumor diagnosis, but its application was limited by the need for manual interpretation and lack of real-time monitoring capabilities. The new inventive concept addresses these limitations by combining the probe with AI-powered image processing, IoT-based sensor networks, blockchain-based secure data sharing, and biocompatible composite materials to create a more powerful, efficient, and accurate system for tumor diagnosis and treatment planning.

The synergistic system comprises the multi-signal fluorescent probe, an AI-powered image processing module for enhanced diagnostic accuracy, an IoT-based sensor network for real-time monitoring of tumor development, a blockchain-based platform for secure storage and sharing of tumor diagnosis data, and a biocompatible composite material for improved probe stability and biocompatibility. The AI module analyzes probe signals to provide accurate diagnosis, while the IoT sensor network enables real-time monitoring. The blockchain platform ensures secure data sharing, and the composite material enhances probe performance. The system can be integrated with AI-driven treatment planning modules and blockchain-based secure data sharing platforms for personalized tumor treatment planning.

The new claims introduce a synergistic combination of distinct technologies, creating a novel system that is more than the sum of its parts. The integration of AI, IoT, blockchain, and new materials with the multi-signal fluorescent probe provides a non-obvious solution to the limitations of the original patent, offering enhanced diagnostic accuracy, real-time monitoring, and secure data sharing.

Alternative embodiments may include integrating the probe with other AI algorithms, using different IoT protocols, or incorporating additional sensors for multi-modal imaging. Variations may include adapting the system for diagnosis and treatment of other diseases or using different biocompatible materials for the composite probe.

The synergistic system has significant commercial potential in the medical diagnostics and healthcare industries, particularly in the fields of cancer diagnosis and treatment. The system's enhanced diagnostic accuracy, real-time monitoring capabilities, and secure data sharing features make it an attractive solution for hospitals, research institutions, and pharmaceutical companies.